Immutep (IMMP) Receivables (2011 - 2025)
Immutep (IMMP) posted Receivables of $24.1 million for Q4 2025, up 281.55% on a QoQ basis from $6.3 million in Q2 2025, and up 439.65% year-over-year from $4.5 million in Q4 2024.
Immutep (IMMP) Receivables (2011 - 2025) Analysis & Trends
Immutep's Receivables history runs 15 years deep, the most recent figure standing at $24.1 million for Q4 2025.
- Quarterly Receivables rose 439.65% year-over-year to $24.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.1 million (up 439.65% YoY) and the FY2025 annual result came in at $6.3 million, up 30.47% from the prior year.
- Receivables was $24.1 million for Q4 2025 at Immutep, up from $6.3 million in the prior quarter.
- Across five years, Receivables topped out at $24.1 million in Q4 2025 and bottomed at $3.3 million in Q4 2022.
- A 5-year average of $6.8 million and a median of $5.0 million in 2021 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables plunged 35.35% — and 2025, when it soared 439.65%.
- Immutep's Receivables stood at $5.1 million in 2021, then slumped by 35.35% to $3.3 million in 2022, then climbed by 21.06% to $4.0 million in 2023, then climbed by 12.48% to $4.5 million in 2024, then surged by 439.65% to $24.1 million in 2025.
- Business Quant data shows IMMP's Receivables at $24.1 million in Q4 2025, $6.3 million in Q2 2025, and $4.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - | 24.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.11 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Dec 31, 2024 | 4.47 Mn |
| Jun 30, 2024 | 4.84 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Jun 30, 2023 | 5.31 Mn |
| Dec 31, 2022 | 3.28 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Dec 31, 2021 | 5.08 Mn |
| Jun 30, 2021 | 4.72 Mn |
| Dec 31, 2020 | 3.88 Mn |
| Jun 30, 2020 | 2.16 Mn |
| Dec 31, 2019 | 3.24 Mn |
| Jun 30, 2019 | 3.64 Mn |
| Dec 31, 2018 | 2.63 Mn |
| Jun 30, 2018 | 2.60 Mn |
| Jun 30, 2017 | 1.65 Mn |
| Mar 31, 2017 | 1.77 Mn |
| Jun 30, 2016 | 125,670.02 |
| Jun 30, 2015 | 245,240.35 |